1. Pfizer. Precedex® (Dexmedetomidine) Product Monograph. Kirkland, QC: Pfizer Canada. Available from URL: https://www.pfizer.ca/sites/default/files/202007/Precedex_PM_E_2Jul2020.pdf. Accessed October 2021.
2. Khan ZP, Ferguson CN, Jones RM. Alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role. Anaesthesia 1999; 54: 146-65.
3. Government of Canada. Summary Basis of Decision - Precedex™. Dexmedetomidine Hydrochloride 100 µg/mL Solution, Intravenous. Health Canada. Available from URL: https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailOne.php?linkID=SBD00112 (accessed October 2021).
4. Venn RM, Hell J, Grounds RM. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care 2000; 4: 302-8.
5. McLaughlin M, Marik PE. Dexmedetomidine and delirium in the ICU. Ann Transl Med 2016; DOI: https://doi.org/10.21037/atm.2016.05.44.